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Abstract
The more stable among the tested samples were samples with saccharose in the concentration of 50–75 mg per cm3.
While adding of L- lysine to samples the most stable activity was discovered in the experimental series of samples with the 
content of lysine of 10 mg per cm3 – activity increased by 54 % as compared to theoretical initial activity of HCG during 
8 weeks. While storing gonadotropin with L-glycine fluctuations of hormone activity in all series of samples were observed. 
Adding of 0.2 mg per cm3 of L-glycine had a more expressedstabilizing effect. Adding of 0.2 mg per cm3 of L-methionine 
produced relativelyhigh and stableactivity ofgonadotropinduring the 6 weeksstorage. Adding of 0.25 mg/cm3 of L-glycine and 
75.50 mg/cm3 of saccharose to experimental samples during 2 weeks at 40 °C provided 69.8 % and 60.7 % saving activity of 
hCG respectively. Activity of gonadotropin in a series of samples with the addition of L- glycine and mannitol was significant-
ly lower and at the end of the study was at an appropriate rate with the control series models. The highest activity of gonadotro-
pin was detected while adding fillers – 10 mg/cm3 L-lysine and 75 mg/ m3 saccharose and mannitol – to recipes as a stabilizer.
Keywords: chorionic gonadotropin, saсcharose, L – lysine, mannitol, L – glycine; hCG (human chorionic gonadotro-
pin), CG (chorionic gonadotropin).
© Iryna Matiukha, Yuriy Slyvchuk, Vasyl Syrvatka, Ivan Gevkan, Oksana Shtapenko, Galina Milovanova
1. Introduction
The gonadotropins form a family of structurally relatedglycoprotein hormones. Typical mem-
bers include chorionicgonadotropin (CG), follicle stimulating hormone (FSH; follitropin), luteinizing 
hormone (LH; lutropin) and thyroidstimulating hormone (TSH; thyrotropin). Human chorionic gonad-
otropin (hCG) is a placental glycoprotein hormone that acts through binding to a G-protein-coupled 
receptor, leading to increased adenylatecyclase activity [1–6]. hCG is a heterodimer consisting of two 
non-covalently associated subunits, α and β, each encoded by a different gene, located on chromosomes 
19 and 7, respectively. Biological activity depends on the association of these subunits [7]. Both subunits 
are glycosylated and glycosylation during biosynthesis is absolutely essential for right folding of each 
subunit. Both subunits have several disulfide bridges and the crystal structures of hCG and human FSH 
reveal that three of the disulfide bridges in both subunits form cystine knots.Within a species the α-sub-
unit is essentially identical for each member of the gonadotropin family; it is also highly conserved from 
species to species. The β-subunits are different for each member, i. e. CG, FSH, TSH and LH, but show 
considerable homology in structure. In humans the α-subunit consists of 92 amino acid residues, whilst 
the β subunit varies in size for each member [9]. The β subunit of hCG is substantially larger than the 
other β subunits in that it contains approximately 34 additional amino acids at the C-terminus referred 
to herein as the carboxy terminal protein (CTP). Relatively pure gonadotropin preparations are commer-
cially available. The stability of proteins in aqueous formulations is generally a problem in pharmaceu-
tical industry. Likewise the stability of aqueous solutions of the gonadotropins is insufficient to allow 
storage for longer times [8]. Therefore, usually those preparations are stored in a dry form, as obtained 
after lyophilization. A stabilized gonadotropin containing lyophilized pharmaceutical formulation is 
disclosed in European Patent № 448,146 (Akzo N. V.). These preparations contain organic carboxylic 
acids, particularly citric acid, and optionally a non-reducing sugar such as sucrose.
Liquid formulations containing the gonadotropin recombinant-hCG stabilized with the 
non-reducing sugar, preferably mannitol, in an aqueous solution in a phosphate buffer at pH 7, are 
disclosed in WO 96/29095. Solutions comprising gonadotropins and a polycarboxylicacid salt are 
known from European Patent № 448,146 (Akzo N. V.). These solutions, containing, for instance, 
citric acid are described for preparing stabilized lyophilised gonadotropin formulations. At the 
storage of such solutions per se for longer times the gonadotropins are insufficiently stable.
It is well known that highly purified proteins with time loose stability, and to maintain the 
hormone activity it is necessare to add some concentration of sucrose such as lactose and mannitol or 
of proteins and aminoacids such as albumin and glycine. However, these means in any case are not 
suitable for injection because of their lack of solubility and allergity or in some cases because of their 
potential toxicity or because of all these effects simultaneously. Also, the storage of such composi-
tions for a longer time does not provide sufficient stabilization activity of gonadotropins in solution. 
However, it is impossible to provide a standard recipe for all proteins and choosing of the best recipe 
requires considerable effort in selection whichactually becomes the main aim of our work. 
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2. Materials and methods
The human chorionic gonadotropin (hCG) was obtained in the Institute of Animal Biology, 
National Academy of Agrarian Science of Ukraine (Director Prof. V. Vlizlo) from the urine of 
pregnant women (12–16 weeks of gestation). To evaluate the influence of filler on the stability of 
gonadotropins activity different samples of human chorionic hormone were prepared, with the con-
tents of 2.500 mIU per ml of different fillers: saccharose, mannitol, lysine, together and separate. 
All samples were prepared using the solution of fillers in a phosphate buffer at pH 7.34 (Fig. 1).
Fig. 1. Scheme of the experiment
The concentration of intact gonadotropin was established by means of electro- and im-
muno-chemiluminescent method based on the difference between total and free hCG [10]. The 
initial concentration of total hCG was 30,175 mIU per mL while the concentration of free hCG was 
375 mIU per mL. Theoretically, the activity of hCG was 29,800 mIU per mL. The samples were 
placed into a thermostat for incubation at the temperature of 40 оC. After each 2 weeks during two 
months the concentration of total (hCG β-hCG) and free (β-hCG) gonadotropin was measured. The 
hCG concentration was determined by the difference between (hCG+β-hCG) and (β-hCG) [11].
3. Results
The results of activity tests performed on HCG during 2, 4, 6 and 8 weeks storage in the 
presence of stabilizers described above are shownin Fig. 2, 3 and Table 1. After two weeks in 
a sample containing 25 mg/cm3 of saccharose, a 53 % reduction of the initial hCG concentration 
was found; in the sample containing 75 mg/cm3 of saccharose, the concentration was higherand 
amounted to almost 68 % of the initial theoretical activity (Fig. 2).
Fig. 2. Dynamics of gonadotropin activity with addition of saccharose and mannitol to the solvent
In the X axi, the time of incubation of hCG with the addition of saccharose and mannitol to 
the solventare presented; in the Y axis the changes of hormone activity in the percentage from the 
initial concentrationare presented
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Thus, it was found thatsaccharoseis an effectivestabilizingagent againstgonadotropin denatur-
ation (Fig. 3).
Fig. 3. Dynamics of gonadotropin activity with the addition of aminoacids to the solvent
In the X axis the time of incubation of hCG with the addition of aminoacids to the solventare present-
ed;in the Y axis the changes of hormone activity in the percentage from the initial concentrationare presented
Changes occurring in all series of samples at thehCG storage in a thermostat at 40 °С after adding 
L-lysine were established in the experiment.The highest activity was found in the first series of experimental 
samples, 51.93 %, containing 10 mg/cm3 of L-lysine in the sample. On the 8th week of storage of samples in an 
incubator, in the 2nd series of experimental samples no changes in hCG activity were observed as compared 
to a 6-week storage while a tendency to an increase of gonadotropins activity in the 1st series of experimental 
samples and to its decrease in the control samples was established.
Therefore, the best results in the maintaining ofhCG concentration on the highest level were obtained 
after adding 10 mg/cm3 of L-lysine during 8 weeks and 0.2 mg/cm3 of L-glycine.
Further investigations were performed on the samples with joint action of sacharoses and amino acids 
in the best concentrations which were obtained before (Table 1).
Table 1
Dynamics of gonadotropin activity with the addition of saccharose and aminoacids to the solvent 
during 2 month of storage at the temperature 40 ºС
Series of samples
Activity of gonadotropin, %
2 weeks 4 weeks 6 weeks 8 weeks
Control 31,4 18,9 15,0 14,1
L-glycine+saccharose 0,25+50 60,7 37,9 37,3 22,8
L-glycine+saccharose 0,25+75 69,8 48,0 38,5 21,4
L-glycine+mannitol 0,25+50 44,7 28,3 27,6 18,6
L-glycine+mannitol 0,25+75 45,2 27,7 15,4 15,1
L-lysine+saccharose 10+50 71,5 45,9 36,2 24,2
L- lysine+saccharose 10+75 78,7 51,2 50,4 39,1
L-lysine+mannitol 10+50 54,2 42,1 39,2 27,4
L-lysine+mannitol 10+75 55,2 54,3 52,4 32,7
The best properties during all incubation period were shownin the samples with L-lysine + saccharose 
10+75 mg/cm3. On the 4 and 6 weeks, the highest level of activity was observed in the samples with L-ly-
sine + mannitol 10+75 mg/cm3.
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4. Discussion
An extensive analysis of the data from literature testifies to the fact that the research of 
optimum methods of stabilization of gonadotropic preparations for their use both in human and 
veterinary medicine is urgent and is being performed by many researchers [12, 13]. The interest to 
the gonadotropic preparations, researchers continue to search the optimal stabilizer of hormones 
activity during their incubation. It has been established that the use, for instance, of mannitol as a 
stabilizing agent does not cause a visible decrease in the activity of the hormone after 24 weeks of 
conservation [14, 15]. The US patent № 5270057 describes a lyophilized composition containing 
gonadotropin (for example, LH, TBG, FSH and hCG) stabilized with polybasic carboxylic acid 
or its salt. Within 6 weeks of incubation at 40 °C, a higher activity of hCG in samples contain-
ing 50−75 mg/cm3 saccharose was established in our investigation. In our investigation we used 
different organic compounds for stabilizing hormone activity for storage during 8 weeks at the 
temperature + 40 °C. Some authors used other temperature regimes and organic components. So, 
they used a competitive radioimmunoassay measuring hCG, hCGβ and hCGβcf together. De Me-
deiros [16] found that hCG is stable at + 4 °C for at least 3 weeks and Mc Chesney [17] found that 
hCG is stable for at least 4 weeks at + 4 °C. 
After incubation in a samplecontaining of saccharosethe concentration ofthe hormonein 
the samples of the 2nd experimental groupwason the same levelwith the controlandconstituted 
about 51 % we obtained in our investigation. After 8weeks ofresearch the hCGactivity in the 
samplesof the second serieswas the lowestand amounted to 20 % of the initial concentration,the 
highestactivity of gonadotropinbeing observed inthe 1st series ofexperimentalsamples – 37 %. 
The storage of samples with mannitol led to a decreased hormone activity by 49 % in the third 
series of samples and by 17.5 and 23.6 % in the samples of the first and second series, respec-
tively. Activity of samples was 30.7, 27.5 and 17.27 % in the 1, 2 and 3 series, respectively, after 
8 weeks of incubation. 
Glycerol provided protection against urea-induced hCG degradation at − 20 °C, and it has 
earlier been shown to protect urinary FSH and LH against degradation at − 20 °C [18, 19]. Our 
aim was to evaluate the stability of hCG, hCGβ, hCGα and hCGβcf in urine during storage at var-
ious temperatures. Since urine contains fairly high concentrations of urea (0.2–0.8 mol/L) that has 
been suggested to cause degradation of LH at − 20 °C (McChesneyetal., 2005), the effect of added 
urea on hCG loss was studied. Lempiäinen et al. evaluated the protective effect of different addi-
tives; glycerol has been shown to prevent the degradation of other gonadotropins, ethylene diamine 
(EDA), which protects proteins against carbamylation caused by urea-derived cyanate, EDTA, and 
bovine serum albumin (BSA) [20].
The studies have shown that the activity of hCG after 2 weeks of storage in the con-
trol series of samples decreased by almost 58 %, in the 2nd series of experimental samples by 
63.56 %, while in the 1st experimental series, where 10 mg/cm3 of L-lysine was introduced, the 
gonadotropin activity was 51.72 % of the initial theoretical activity of hCG. After 4 weeks of 
storage of samples, a tendency to a further reduction of the gonadotropin concentration was 
observed in all series. The highest activity was found in the first series of experimental sam-
ples, 51.93 %, containing 10 mg/cm3 of L-lysine in the sample. On the 8th week of storage of 
samples in an incubator, in the 2nd series of experimental samples no changes in hCG activity 
were observed, as compared to a 6-week storage, while a tendency to an increase of gonad-
otropins activity in the 1st series of experimental samples and to its decrease in the control 
samples was established.
Adding of 0.2 mg/cm3 of L-glycine after 2 weeksleads to 53 % preservation of the hCG activ-
ity, accordingto the theoreticalinitialactivity, whereas in the control samples and experimental series, 
where 10 mg/cm3 of L-glycine was added, the hCG concentration decreased by 57 and 62 %, respec-
tively. After 4-weeks storage an increase of hormone activity by 16 % in the samples with 10 mg/cm3 
of L-glycine were found as compared to 2 weeks of incubation. In the rest of samples the hormone 
activity continued to decline. However, at the 8th week of storage in the control and first experimental-
seriesof samples it was reduced andremained on thesame level, while in the 2nd series of experimental 
samples it increased by almost 10 % in respect to the previous activity of gonadotropin.
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In the 2nd experimental series of samples containing 0.2 mg/cm3 of L-methionine, the hCG 
activity was almost 52 % of the theoretical initial activity on the 2nd week of incubation. These 
indicators in this series of samples were at the same level at the 4th week of storage, however, on 
the 6th week of storage the hCG concentration decreased by 4 %. The activity of gonadotropin in 
the 1st experimental series of samples containing 10 mg/cm3 of L-methionine after two weeks of 
cultivation was the lowest and amounted to only 38.41 % of the initial theoretical concentration 
and remained at the same level within 6 weeks of storage. In the samples with 0.25 mg/cm3 of 
L-glycine + 75 or 50 mg/cm3 of saccharose, its activity was the highest and constituted 69.8 % 
and 60.7 %, respectively, of the initial activity of gonadotropin. After 4 and to 8 weeks of incu-
bation the tendency to decrease in the hormone activity was observed in all series of samples. 
In the samples with L-lysine + saccharose after 2 weeks the activity of hCG was on the highest 
level as compared to other groups with added stabilizer – 71.5 and 78.5 % in the samples with 
L-lysine + saccharose 10+50 mg/cm3 and L-lysine + saccharose 10+75 mg/cm3, respectively. In 
the samples with mannitol + L-lysine, the hCG activity decreased by 45 %. The best properties 
during all incubation period were shown in the samples with L-lysine + saccharose 10+75 mg/cm3. 
On the 4 and 6 weeks of storage, the highest level of activity was observed in the samples with 
L-lysine + mannitol 10+75 mg/cm3. 
5. Conclusions
The best properties during all incubation period were shown in the samples with L-lysine + sac-
charose 10+75 mg/cm3. On the 4 and 6 weeks of storage the highest level of activity was observed 
in the samples with L-lysine + mannitol 10+75 mg/cm3. Obtained results can be used in the prepa-
ration effective, modern and save medical substances for hormonal therapy in animals.All these 
literature data and also our investigation confirm the need of find in gorganic substances to en sure 
optimal conditionsfors to rage of high activity HCG during incubation for future use in human and 
veterinary medicine.
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